| GPX3 promoter methylation predicts platinum sensitivity in colorectal cancer L Pelosof, S Yerram, T Armstrong, N Chu, L Danilova, B Yanagisawa, ... Epigenetics 12 (7), 540-550, 2017 | 57 | 2017 |
| Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells A Sharma, R Vatapalli, E Abdelfatah, K Wyatt McMahon, Z Kerner, ... PloS one 12 (4), e0176139, 2017 | 32 | 2017 |
| CHFR silencing or microsatellite instability is associated with increased antitumor activity of docetaxel or gemcitabine in colorectal cancer L Pelosof, SR Yerram, N Ahuja, A Delmas, L Danilova, JG Herman, ... International journal of cancer 134 (3), 596-605, 2014 | 29 | 2014 |
| DNA-intercalators causing rapid re-expression of methylated and silenced genes in cancer cells MZ Hossain, MA Healey, C Lee, W Poh, SR Yerram, K Patel, NS Azad, ... Oncotarget 4 (2), 298, 2013 | 24 | 2013 |
| Hypersensitivities for acetaldehyde and other agents among cancer cells null for clinically relevant Fanconi anemia genes S Ghosh, S Sur, SR Yerram, C Rago, AK Bhunia, MZ Hossain, BC Paun, ... The American journal of pathology 184 (1), 260-270, 2014 | 18 | 2014 |
| A thymidylate synthase ternary complex-specific antibody, FTS, permits functional monitoring of fluoropyrimidines dosing K Patel, SR Yerram, NA Azad, SE Kern Oncotarget 3 (7), 678, 2012 | 15 | 2012 |
| Correction: Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells A Sharma, R Vatapalli, E Abdelfatah, KW McMahon, Z Kerner, ... PloS one 15 (11), e0242750, 2020 | 1 | 2020 |
| GPX3 promoter hypermethylation predicts platinum sensitivity in colorectal cancer cells. L Pelosof, S Yerram, N Azad, J Herman Cancer Research 73 (8_Supplement), 652-652, 2013 | 1 | 2013 |
| Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells (vol 12, e0176139, 2017) A Sharma, R Vatapalli, E Abdelfatah, KW McMahon, Z Kerner, ... PLOS ONE 15 (11), 2020 | | 2020 |
| GPX3 as a predictive biomarker in gastrointestinal malignancies. LC Pelosof, SR Yerram, B Yanagisawa, NS Azad, JG Herman Journal of Clinical Oncology 32 (3_suppl), 499-499, 2014 | | 2014 |
| Acetaldehyde and drug hypersensitivities of Fanconi anemia defects: Implications for cancer initiation, prevention, and therapy. S Ghosh, S Sur, SR Yerram, C Rago, AK Bhunia, MZ Hossain, BC Paun, ... Cancer Research 73 (8_Supplement), 3580-3580, 2013 | | 2013 |
| MC13-0076 CHFR silencing and microsatellite instability as predictors of sensitivity to docetaxel and gemcitabine in colorectal cancer L Pelosof, S Yerram, N Ahuja, A Delmas, L Danilova, J Herman, N Azad European Journal of Cancer, S33, 2013 | | 2013 |
| Abstract LB-353: Development of thymidylate synthase ternary complex-specific antibody: A new way to tailor 5-fluorouracil dosing K Patel, SR Yerram, SE Kern Cancer Research 72 (8_Supplement), LB-353-LB-353, 2012 | | 2012 |
| Developing Mathematical Models for Predicting Escherichia Coli Concentrations at Wisconsin Beaches Using Regressions SR Yerram | | 2009 |
